CV Sciences, Inc. Logo
  • Home
  • About Us
    • Clinical Pipeline
    • Management Team
    • Board Of Directors
    • History
  • Pipeline
  • Consumer Products
  • Investors
    • Overview
    • News / Events
    • Company Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Contact Us

Investors

Investors
  • Overview
  • News / Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Information
  • Stock Data
  • SEC Filings
  • Corporate Governance

CV Sciences is a consumer wellness company specializing in nutraceuticals and plant-based foods.

Press Releases

CV Sciences, Inc. Receives Notice of Patent Allowance from USPTO for Proprietary Cannabidiol (CBD) and Nicotine Formulation for Treating Smokeless Tobacco Addiction

Apr 6, 2020

CV Sciences, Inc. Reports Fiscal Year-End 2019 Financial Results

Mar 16, 2020

CV SCIENCES, INC. RESCHEDULES FULL YEAR 2019 RESULTS CONFERENCE CALL TO MARCH 16, 2020

Mar 10, 2020

CV Sciences, Inc. to Announce Full Year 2019 Results on March 10, 2020

Feb 26, 2020

CV Sciences, Inc. Launches Updated +PlusCBD™ Oil Website to Enhance User Experience and Drive Increased E-Commerce Sales

Jan 23, 2020

Farmers Insurance Open Selects +PlusCBD™ Oil as Their First-Ever CBD Sponsor

Jan 21, 2020

CV Sciences, Inc. to Participate at the 22nd Annual ICR Conference

Jan 8, 2020

Tim Hitchman, PhD, Joins CV Sciences, Inc. as Director of Operations

Dec 17, 2019

CV Sciences to Present at the 12th Annual LD Micro Main Event

Dec 3, 2019

CV Sciences, Inc. Announces New Distribution Partnership With Southeastern Grocers

Nov 11, 2019
RSS
    • 1...
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • 11
    • 12
    • 13
    • 14
    • ...24
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed

    © CV Sciences, Inc. All Rights Reserved.

    • Home
    • About Us
      ▼
      • Clinical Pipeline
      • Management Team
      • Board Of Directors
      • History
    • Pipeline
    • Consumer Products
    • Investors
      ▼
      • News / Events
      • Company Information
      • Stock Data
      • SEC Filings
      • Corporate Governance
    • Contact Us